Medivive Review: Price, Pros & Cons

Medivive prescribes compounded semaglutide and compounded tirzepatide, both as once-weekly injections, and it doesn't publish a price for either. You see your exact, all-in price once a provider has matched you to a treatment plan, before you commit to anything. There's no membership fee and no insurance needed.

Medivive says that price covers the medication, a provider check-in every 30 days, refill coordination, and guidance on nutrition and movement from a bilingual care team. There's no long-term contract, and you can pause or cancel at any time. Because nothing is listed upfront, ask two things when your price appears: what the plan costs at higher doses, and how often you're billed.

Medivive's intake isn't a questionnaire. You start by chatting with an AI clinical assistant, in English or Spanish, that asks about your goals and history in your own words. You don't create an account or give an email address until a plan has been matched. The assistant only suggests options. A licensed clinician in your state reviews your case and makes every prescribing decision, and treatment isn't guaranteed.

Prescriptions are written by TrueEval Medical Group, a telehealth medical group that says it covers all 50 states. Its lead clinician is Shannon M. Smith, MSN, APRN, FNP-C, PMHNP-BC, a nurse practitioner and Navy veteran. A medical director oversees clinical standards but isn't named.

No in-person visit is needed. Your provider may ask for bloodwork first if you have a history of thyroid or pancreatic conditions or take other metabolic medications.

Medivive lays out what to expect:

1. Week 1. Your provider sets a low starting dose and the medication ships from a licensed 503A pharmacy, one that compounds each prescription for a named patient, in plain packaging.
2. Week 4. The first check-in reviews side effects and response, and your dose may go up.
3. Week 12. Most people have settled on a dose they tolerate.
4. Week 24 and on. Monthly check-ins continue for maintenance.

The pharmacy isn't named. Medivive won't treat anyone with a personal or family history of medullary thyroid cancer or MEN 2, or anyone pregnant, planning pregnancy or breastfeeding.

• No brand-name Wegovy or Zepbound and no pill form are offered.
• Medivive also sells at-home lab panels, hormone therapy, ED and hair treatment and NAD+, all through the same provider group. None is required for weight care.
• A refund policy isn't published. Ask what happens to your payment if you're not approved.

Compounded semaglutide and tirzepatide are not FDA-approved.